David H. Viskochil

Photos

3773 W 12600 S
Riverton, UT 84065
David Viskochil, MD, PhD, is professor of pediatrics and one of the clinical geneticists in the Division of Medical Genetics. He received his bachelor’s degree in biology from the University of Arizona, and his doctorate in biochemistry and medical degree from the University of North Carolina 1985. He completed his pediatric residency and clinical genetics fellowship at the University of Utah Affiliated Hospitals.His research has focused on the molecular genetics of the neurofibromatosis type 1 (NF1) gene, and bone health and cancer malignancy in patients with NF1. He performs translational research in NF1-related manifestations, and is the local principal investigator for the NF Clinical Trials Consortium. He is involved in clinical trials for NF1 and lysosomal storage disorders. He was the recipient of a Young Investigator Award from the National Neurofibromatosis Foundation (NNFF) and a K-08 award for NF1-related research. Ongoing funding has come from the Department of Defense NF Research Program, NINDS of the NIH, and the Shriners Research Foundation. He has published over 50 research and clinical reports and serves on study sections for the Department of Defense and NIH. David has an academic clinical practice that includes genetics patients who access care through Primary Children’s Medical Center, Huntsman Cancer Institute, the University of Utah Neurosciences Center (Adult NF Clinic), and the Shriners Hospital. He serves as co-Director of the NF Clinic at the University of Utah and is the Director of Clinical Genetics Services in the Division of Medical Genetics.David’s administrative roles are varied and include University and national positions. He serves as Chair of the Clinical Care Advisory Board of the Children’s Tumor Foundation (national NF support organization), Chair of the Utah State Department of Health Genetic Advisory Committee, and is member on the Advisory Board for the Mucopolysaccharidosis I Registry. He serves as Medical Director for the University of Utah Graduate Program in Genetic Counseling, and is one of the associate editors of the American Journal of Medical Genetics. He serves on the IRB for the University of Utah, and he supervises the Clinical Genetics Research Program embedded in the Center for Clinical Translational Science at the University of Utah. David shoots hoops and plays golf.
Owner verified
See a problem?

You might also like

Mark Deneau

Mark Deneau

Dr. Mark Deneau is the medical director of the Pediatric Inflammatory Bowel Disease Clinic at Primary Children’s Hospital / Intermountain Healthcare. He leads a multidisciplinary team caring for children and young adults with Crohn’s disease and ulcerative colitis, combining clinical expertise with a deeply personal understanding—Dr. Deneau has lived with IBD himself since his teenage years. That experience shapes his approach to care, allowing him to connect with patients and families on a meaningful level and help them live their best possible lives. When it’s helpful, he’s open about sharing his own journey through medications and surgery. In addition to his work with IBD, Dr. Deneau treats a wide range of general pediatric gastroenterology conditions, including irritable bowel syndrome (IBS), chronic abdominal pain, and constipation. He takes a thoughtful, conservative approach—avoiding unnecessary procedures or excessive testing whenever possible. He is also part of the liver diseases program and sees patients admitted to the hospital with biliary atresia and liver transplantation. A dedicated educator, Dr. Deneau teaches and mentors medical students, pediatric residents, and fellows, and has received multiple teaching awards for his excellence in communication. He brings this same clarity and compassion to his clinical work, ensuring patients and families understand their diagnoses, treatments, and medications. He draws on humor to connect with families and ease difficult conversations His research focuses on liver disease in children with IBD, particularly primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). He also leads and participates in hospital-wide quality improvement initiatives aimed at enhancing patient safety and reducing the cost of care for gastrointestinal conditions. Outside of the hospital, you can find him mountain biking or working on a massive Lego project with his boys.
United StatesUtahRivertonDavid H. Viskochil

Yext